OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Jazz Pharmaceuticals PLC/  IE00B4Q5ZN47  /

NASDAQ
9/19/2024  10:00:00 PM Chg. +1.7250 Volume Bid10:58:18 PM Ask10:58:18 PM Market Capitalization Dividend Y. P/E Ratio
111.2900USD +1.57% 974,442
Turnover: 72.74 mill.		 108.2200Bid Size: 100 114.3000Ask Size: 100 6.87 bill.USD - 16.99
GlobeNewswire 8/22 Zymeworks Announces Participation in Upcoming Investor Conferences
GlobeNewswire 8/22 Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with th...
GlobeNewswire 8/8 Werewolf Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 8/1 Zymeworks Announces Share Repurchase Program of up to $60 Million of its Common Stock
GlobeNewswire 8/1 Zymeworks Provides Corporate Update and Reports Second Quarter 2024 Financial Results
GlobeNewswire 7/30 Zymeworks Announces Participation in Upcoming Investor Conferences
GlobeNewswire 7/25 Zymeworks Appoints Leone Patterson as Chief Business and Financial Officer
GlobeNewswire 7/22 Chain Bridge I to Acquire Phytanix Bio, Creating a New Public Company Focused on Developing Next Gen...
GlobeNewswire 7/22 Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate ...
Newsfile Corp 7/17 Analysts Hunt for Undervalued Biotech Stocks
GlobeNewswire 7/11 Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024
GlobeNewswire 6/17 Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-c...
GlobeNewswire 6/11 CanaQuest Announces Key Appointments to Team to Drive CQ-001 through Clinical Trials
GlobeNewswire 6/10 Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Secon...
GlobeNewswire 5/28 NodThera Announces Appointment of Daniel Swisher as Chief Executive Officer
GlobeNewswire 5/28 Zymeworks Announces Participation in Upcoming Investor Conferences
GlobeNewswire 5/3 Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/2 Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
GlobeNewswire 4/30 Zymeworks Announces Participation in Upcoming Investor Conferences
GlobeNewswire 4/15 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
GlobeNewswire 4/11 Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
GlobeNewswire 3/28 Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
GlobeNewswire 3/28 Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Development
GlobeNewswire 3/27 Zymeworks Announces Participation in Upcoming Investor Conferences
GlobeNewswire 3/7 Werewolf Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Busin...